Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cellev8 Nutrition's Total Stockholders Equity for the quarter that ended in Nov. 2015 was $-9.34 Mil. Cellev8 Nutrition's Total Assets for the quarter that ended in Nov. 2015 was $0.49 Mil.
Therefore, Cellev8 Nutrition's Equity to Asset Ratio for the quarter that ended in Nov. 2015 was -19.14.
The historical rank and industry rank for Cellev8 Nutrition's Equity-to-Asset or its related term are showing as below:
CELV's Equity-to-Asset is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.55 * Ranked among companies with meaningful Equity-to-Asset only.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Cellev8 Nutrition Equity-to-Asset Related Terms
Cellev8 Nutrition Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Cellev8 Nutrition's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CELV vs LFVN, MAMA, NATR: Equity-to-Asset Comparison
For the Packaged Foods subindustry, Cellev8 Nutrition's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellev8 Nutrition Equity-to-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Cellev8 Nutrition's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Cellev8 Nutrition's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Cellev8 Nutrition's Equity to Asset Ratio for the fiscal year that ended in Nov. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellev8 Nutrition (CELV) has a Equity-to-Asset of -19.14 as of Nov. 2015. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cellev8 Nutrition and its competitors.
Is Cellev8 Nutrition's Equity-to-Asset too high?
Cellev8 Nutrition's current Equity-to-Asset is -19.14. Overall, Cellev8 Nutrition has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Cellev8 Nutrition's Equity-to-Asset compare to LFVN and MAMA?
Cellev8 Nutrition's Equity-to-Asset of -19.14 can be compared against companies in the Consumer Packaged Goods industry. The industry median Equity-to-Asset is 0.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Consumer Packaged Goods company?
The median Equity-to-Asset among Consumer Packaged Goods companies is 0.55, based on 2,012 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cellev8 Nutrition and its competitors. For the Consumer Packaged Goods industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellev8 Nutrition's current Equity-to-Asset is -19.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellev8 Nutrition stock overvalued right now?
Cellev8 Nutrition (CELV) has a current Equity-to-Asset of -19.14. The current Equity-to-Asset is -19.14. Cellev8 Nutrition's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cellev8 Nutrition (CELV), the current Equity-to-Asset is -19.14 as of Nov. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cellev8 Nutrition Inc is engaged in the development, markets, and sells a line of proprietary blended cellular therapeutics named Cellev8. Its products are based on formulations containing Superoxide Dismutase (SOD) and are developed for health-related applications.
30GF Score
Get the complete analysis for CELV
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CELV has been successfully added to your 
